Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Yuasa

Showing results (291-300 of 305) with videos related to

Pageof 31
Sort By:
Nature Nanotechnology|July 23, 2024
High-resolution three-dimensional imaging of topological textures in nanoscale single-diamond networksD Karpov, K Djeghdi, M Holler, et al.
Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment|March 21, 2007
X-ray microbeams: Tumor therapy and central nervous system researchF A Dilmanian, Y Qu, S Liu, et al.
Nature Genetics|October 5, 2001
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily geneH Date, O Onodera, H Tanaka, et al.
The Japanese Journal of Antibiotics|January 1, 1983
[Clinical studies on cefadroxil in the field of pediatrics]T Motohiro, K Tanaka, T Koga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trialsD Y C Heng, T K Choueiri, B I Rini, et al.
The Japanese Journal of Antibiotics|July 1, 1982
[Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants]T Motohiro, K Tanaka, T Koga, et al.
ESMO Open|June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumK Takemura, T Yuasa, A Lemelin, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
The Japanese Journal of Antibiotics|February 1, 1983
[Clinical results of latamoxef on pertussis]M Minamitani, K Hachimori, S Nakazawa, et al.
British Journal of Cancer|April 3, 2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDCJ J Ko, T K Choueiri, B I Rini, et al.
Pageof 31

Showing results (291-300 of 305) with videos related to

Sort By:
Pageof 31
Nature Nanotechnology|July 23, 2024
High-resolution three-dimensional imaging of topological textures in nanoscale single-diamond networksD Karpov, K Djeghdi, M Holler, et al.
Nuclear Instruments & Methods in Physics Research. Section A, Accelerators, Spectrometers, Detectors and Associated Equipment|March 21, 2007
X-ray microbeams: Tumor therapy and central nervous system researchF A Dilmanian, Y Qu, S Liu, et al.
Nature Genetics|October 5, 2001
Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily geneH Date, O Onodera, H Tanaka, et al.
The Japanese Journal of Antibiotics|January 1, 1983
[Clinical studies on cefadroxil in the field of pediatrics]T Motohiro, K Tanaka, T Koga, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trialsD Y C Heng, T K Choueiri, B I Rini, et al.
The Japanese Journal of Antibiotics|July 1, 1982
[Pharmacokinetic, bacteriological and clinical studies of cefotaxime in newborn and immature infants]T Motohiro, K Tanaka, T Koga, et al.
ESMO Open|June 20, 2024
Prognostic significance of absolute lymphocyte count in patients with metastatic renal cell carcinoma receiving first-line combination immunotherapies: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumK Takemura, T Yuasa, A Lemelin, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
Real-world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumI Stukalin, J C Wells, J Graham, et al.
The Japanese Journal of Antibiotics|February 1, 1983
[Clinical results of latamoxef on pertussis]M Minamitani, K Hachimori, S Nakazawa, et al.
British Journal of Cancer|April 3, 2014
First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDCJ J Ko, T K Choueiri, B I Rini, et al.
Pageof 31